Clinical Trial Update: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial comparing VitroGro ECM to placebo for venous leg ulcers has been withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• VitroGro ECM

Snippet

Sponsor: Tissue Therapies Ltd. | Conditions: Venous Leg Ulcer | Phase 2, Phase 3 | Status: WITHDRAWN